July 2022 "Not even a PIPE financing could save X4 Pharmaceuticals from enacting layoffs and trimming The move comes less than three weeks after X4 pulled together a $55 million PIPE and amended a loan facility

Therapeutics To Release Half-Year 2023 Financial Results And Host Conference Call On August 10, 2023 X4 Pharmaceuticals Closes $115 Million Loan Facility with Hercules Capital Gene-to-structure and Europe adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial Crinetics Pharmaceuticals Reports Second Quarter 2023 Financial Results And Provides Corporate Update X4 Pharmaceuticals Announces

Industry News X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market Andrew

Evi Kostenis "Pharmacist by training - PhD in Pharmacology - Postdoc at the NIH with Dr. Pharmacology at 7TM Pharma in Denmark; Full professor, department chair and director of the institute for pharmaceutical

Globally, the result was a drastic HIV-1 R5, but not X4, overproduction in EBI2-transduced cells.

Khaled Abdelrahman graduated in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University He is also a Registered Pharmacist in Canada and held two of the most prestigious Clinician Postdoctoral